MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fphar.2025.1526709

Медицинская библиотека · Frontiers in pharmacology · 2025

Metformin in gynecological disorders: pathogenic insights and therapeutic implications.

Nie Ping, Wang Minghua, Mo Yan, Zhou Hong, Zha Qingbing, Lash Gendie E, Li Ping

СтатьяОбзорПеревод в очереди

Аннотация

Metformin, the most widely used anti-diabetic drug, has been demonstrated to exert various effects, including antioxidant, anti-inflammatory, anti-tumor, and cardioprotective properties. Due to its affordability and low toxicity profile, metformin is increasingly used to prevent or treat a wide range of gynecological disorders, as evidenced by epidemiological studies, clinical trials, and animal and in vitro studies. Trial findings for non-cancer conditions such as endometriosis, premature ovarian failure (POF), and uterine fibroids remain controversial and insufficient. However, most current clinical trials for polycystic ovarian syndrome (PCOS) and gynecological malignancies are ongoing phase II-III trials. The pharmacological effects of metformin have been shown to target the insulin-like growth factor (IGF), AMP-activated protein kinase (AMPK), phosphatidylinositol 3-kinase (PI3K)/AKT, MAPK, NF-κB, and other signal transduction pathways, highlighting its potential in the treatment of gynecological disorders. In this review, we discuss the biological impacts of metformin and the mechanisms of action pertinent to the treatment of different gynecological disorders.

Для цитирования: Nie Ping, Wang Minghua, Mo Yan, Zhou Hong, Zha Qingbing, Lash Gendie E, Li Ping. Metformin in gynecological disorders: pathogenic insights and therapeutic implications.. Frontiers in pharmacology. 2025. DOI: 10.3389/fphar.2025.1526709.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.